25.07.2012
- GlaxoSmithKline warned on Wednesday that sales in 2012 would be flat as pressure on drug prices intensifies in Europe, due to government austerity measures aimed at curbing...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
21.07.2012
- Myriad Genetics illegally patented acts of nature when it claimed ownership of two genes linked to cancer, the federal government told an appeals court on Friday. Lawyers from...
19.07.2012
- Actelion raised its earnings outlook for 2012 on Thursday as cost cuts helped Europe's biggest biotech company to post a first-half profit despite its most important drug facing...
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
18.07.2012
- Lower prices, higher taxes and fewer drugs paid for by the state could be the new regime for France's pharmaceutical industry when the government details plans in September for €2...
18.07.2012
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first...
16.07.2012
- GlaxoSmithKline is expected to announce an agreement to acquire Human Genome Sciences for about $2.8 billion as soon as Monday, ending three months of its hostile pursuit of the U...
12.07.2012
- AstraZeneca has clinched two new deals in neuroscience, underlining the drugmaker's increasing reliance on external projects to refill a sparse pipeline as it tests a new low-cost...
04.07.2012
- This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As...
